Randomized Controlled Trial of Health Care to Elderly Patients. - Full Text View

Sponsors and Collaborators:	Norwegian University of Science and Technology The Royal Norwegian Ministry of Health
Information provided by:	Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:	NCT00235404

Purpose

To study the efficacy of multicomponent treatment and care for patients with acute illness or deterioration of a chronic disease at a nursing home in primary health care compared to traditional treatment at hospital.

Condition	Intervention	Phase
Congestive Heart Failure Angina Pectoris Asthma Pneumonia Fractures	Procedure: Multicomponent treatment	Phase IV

MedlinePlus related topics: Angina Asthma Heart Failure Nursing Homes Pneumonia

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:	Specialized Treatment and Care Intervention at a Primary Level in a Nursing Home Compared to Conventional Treatment at a Hospital: a Randomized Controlled Trial.

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:

Number of readmisisons within 60 days
Number of deaths within six months and one year
Need of home nursing services after six and twelve months
Number of days initially hospitalized

Secondary Outcome Measures:

Costs

Estimated Enrollment:	128
Study Start Date:	September 2003
Study Completion Date:	May 2005

Detailed Description:

Managers at St. Olavs University Hospital and the City of Trondheim local authority decided in 2001 to establish a reinforced department at a nursing home with a multicomponent approach to patient treatment.

In the study treatment at a nursing home will be compared with conventional treatment in ordinary hospital beds in medical, surgical and orthopedic departments at a hospital. Participating doctors at the hospital together with general practitioners shall develope inclusion criteria through Delphi technique. Eligible participants will be hospitalized from their ordinary home and expected to return to home after treatment. When an eligible patient is identified and accepted for inclusion, randomization will be performed by the Clinical Research Department at the Faculty of Medicine.

Eligibility

Ages Eligible for Study:	60 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Participating doctors at the hospital together with general practitioners shall develope inclusion criteria through Delphi technique.

Exclusion Criteria:

Participating doctors at the hospital together with general practitioners shall develope exclusion criteria through Delphi technique.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00235404

Locations

Norway
Faculty of Medicine, The Norwegian University of Science and Technology (NTNU)
Trondheim, Norway, 7489

Sponsors and Collaborators

Norwegian University of Science and Technology

The Royal Norwegian Ministry of Health

Investigators

Study Chair:

Roar Johnsen

The Norwegian University of Science and Technology (NTNU)

More Information

Study ID Numbers:	REK 037-03
Study First Received:	October 7, 2005
Last Updated:	April 18, 2007
ClinicalTrials.gov Identifier:	NCT00235404
Health Authority:	Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:

Treatment of elderly.
Nursing home.
Rehabilitation.
Readmissions.

Study placed in the following topic categories:

Heart Failure
Heart Diseases
Myocardial Ischemia
Fractures, Bone
Angina Pectoris
Vascular Diseases
Asthma
Pain

Ischemia
Chest Pain
Signs and Symptoms
Respiratory Tract Infections
Respiratory Tract Diseases
Lung Diseases
Pneumonia

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009